MedTrace Logo

Adjuntive Probiotic Therapy in Treating Urinary Tract Infections in Spinal Cord Injury

NCT00594594 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2009-07-07

No results posted yet for this study

Summary

We hypothesize that probiotic Lactobacillus can augment antibiotic treatment of symptomatic urinary tract infection (UTI) in spinal cord injured patients, and also increase the time to the next episode of UTI.

Conditions

Interventions

OTHER

Probiotic Lactobacillus GR-1 and RC-14

Two capsules of Lactobacillus GR-1 and RC-14 daily for 12 months

Sponsors & Collaborators

  • Ontario Neurotrauma Foundation

    collaborator OTHER

  • London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    lead OTHER

Principal Investigators

  • Patrick J Potter, MD FRCPC · St. Joseph's Health Care Centre, Parkwood Hospital, Lawson Health Research Institute

  • Gregor Reid, PhD, MBA · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

  • Keith Hayes, PhD · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

  • Kingsley C Anukam, PhD · Lawson Health Research Institute, [email protected]

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00594594 on ClinicalTrials.gov